Industry News
Simon McKeon to give National Press Club Address
AusBiotech has welcomed news that Simon McKeon AO will speak at the National Press Club in Canberra about the Strategic Review of Health and Medical Research in Australia. [ + ]
Analytica close to US, EU filings for PeriCoach
Analytica (ASX:ALT) will soon be ready to file EU CE Mark and US 510(k) submissions for PeriCoach, a device for treating female urinary incontinence that is already approved in Australia. [ + ]
pSivida partner files fourth US NDA for Iluvien
pSivida (ASX:PVA) licensee Alimera Sciences has made its third resubmission of its US New Drug Application for diabetic macular edema treatment Iluvien. [ + ]
GI Dynamics hits Netherlands reimbursement milestone
A Dutch hospital has won approval to be reimbursed for some procedures involving GI Dynamics' (ASX:GID) EndoBarrier so that healthcare authorities can evaluate allowing nationwide reimbursement. [ + ]
Academy Fellowships
Twenty-one new fellows have been elected to the Australian Academy of Science. [ + ]
A vaccine for middle ear infections
A team of international researchers has moved a step closer to developing a vaccine to protect against middle ear infection, which could also be used for those with poor lung function. [ + ]
Extreme weather directs insect and reptile distribution
The distribution of cold-blooded creatures such as insects, spiders and skinks is predicted to shift rapidly due to extreme weather events associated with climate change. [ + ]
Crude oil linked to heart defects in fish
Oil spills, such as the 2010 Deepwater Horizon spill in the Gulf of Mexico, cause heart defects in developing fish embryos. [ + ]
Government releases statement on the Pharmaceutical Patents Review
The federal government last week released a statement on the Pharmaceutical Patents Review report, confirming it "has no plans to respond to the report at this stage". [ + ]
Novogen JV's ovarian cancer drug effective in vivo
CanTx, a JV between Novogen (ASX:NRT) and Yale University, said its lead drug candidate Trx-1 induced an anti-tumoural effect in a mouse model of ovarian cancer. [ + ]
Prima adds three more experts to advisory board
Prima BioMed (ASX:PRR) has chosen three gynaecological oncology experts to join its clinical advisory board as it prepares for a new trial of CVac in epithelial ovarian cancer. [ + ]
2014 Fellows of the Australian Academy of Science announced
The Australian Academy of Science has announced the election of 21 leaders in Australian science to its Fellowship. [ + ]
GE acquires strategic assets from Thermo Fisher Scientific
GE Healthcare has completed its acquisition of three businesses from Thermo Fisher Scientific: HyClone cell culture media, Dharmacon RNAi gene modulation and Sera-Mag magnetic beads. [ + ]
GTG reaches settlement deal with Promega
Genetic Technologies (ASX:GTG) has reached a deal to license its genomic mapping patents to US-based Promega Corporation. [ + ]
Sirtex and Guerbet team for liver cancer studies
Sirtex Medical (ASX:SRX) has signed an agreement to evaluate using its SIR-Spheres microspheres in conjunction with Guerbet's Lipidol to treat a range of liver cancers. [ + ]
